These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6201487)

  • 41. The sorbitol pathway. Enzyme localization and content in normal and diabetic nerve and cord.
    Gabbay KH; O'Sullivan JB
    Diabetes; 1968 May; 17(5):239-43. PubMed ID: 4384869
    [No Abstract]   [Full Text] [Related]  

  • 42. Sorbitol, inositol and nerve conduction in diabetes.
    Gillon KR; Hawthorne JN
    Life Sci; 1983 Apr; 32(17):1943-7. PubMed ID: 6835015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sorbitol, phosphoinositides and Na K-ATPase in the pathogenesis of diabetic complications].
    Greene DA; Sima AA; Lattimer SA
    Journ Annu Diabetol Hotel Dieu; 1988; ():105-17. PubMed ID: 2845181
    [No Abstract]   [Full Text] [Related]  

  • 44. Free and lipid inositol, sorbitol and sugars in sciatic nerve obtained post-mortem from diabetic patients and control subjects.
    Mayhew JA; Gillon KR; Hawthorne JN
    Diabetologia; 1983 Jan; 24(1):13-5. PubMed ID: 6825977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Free sugars in alloxan diabetic rat nerve.
    Stewart MA; Sherman WR; Anthony S
    Biochem Biophys Res Commun; 1966 Mar; 22(5):4-91. PubMed ID: 5947321
    [No Abstract]   [Full Text] [Related]  

  • 46. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve.
    Lee PG; Hohman TC; Cai F; Regalia J; Helke CJ
    Exp Neurol; 2001 Jul; 170(1):149-61. PubMed ID: 11421592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Axonal transport of choline acetyltransferase and 6-phosphofructokinase activities in genetically diabetic mice.
    Calcutt NA; Willars GB; Tomlinson DR
    Muscle Nerve; 1988 Dec; 11(12):1206-10. PubMed ID: 2467203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration.
    Skundric DS; Lisak RP
    Exp Diabesity Res; 2003; 4(4):303-12. PubMed ID: 14668051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limitations of the polyol hypothesis in the pathobiology of experimental diabetic neuropathy.
    Tomlinson DR; Carrington AL; Diemel LT; Ettlinger CB; Smith WJ; Fernyhough P
    Diabet Med; 1993; 10 Suppl 2():27S-30S. PubMed ID: 8334836
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pathobiochemistry of the late-onset diabetic syndrome].
    Wieland OH
    Ther Ggw; 1974 Sep; 113(9):1448-63. PubMed ID: 4280154
    [No Abstract]   [Full Text] [Related]  

  • 51. [Recent advances in the pathogenesis of diabetic neuropathy].
    Umehara F
    Nihon Rinsho; 1989 Nov; 47(11):2516-20. PubMed ID: 2601065
    [No Abstract]   [Full Text] [Related]  

  • 52. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR; Hawthorne JN; Tomlinson DR
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
    Greene DA
    Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats.
    Wright RA; Nukada H
    Brain; 1994 Dec; 117 ( Pt 6)():1395-407. PubMed ID: 7820575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diabetic microangiopathies].
    Daumerie-Goffinet C; Lambert AE
    Acta Clin Belg; 1978; 33(4):240-54. PubMed ID: 373352
    [No Abstract]   [Full Text] [Related]  

  • 56. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.
    Dyck PJ; Sherman WR; Hallcher LM; Service FJ; O'Brien PC; Grina LA; Palumbo PJ; Swanson CJ
    Ann Neurol; 1980 Dec; 8(6):590-6. PubMed ID: 7212646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
    Tomlinson DR; Mayer JH
    Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Myo-inositol].
    Nakamura J; Hotta N
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():129-34. PubMed ID: 9513403
    [No Abstract]   [Full Text] [Related]  

  • 59. [Diabetic neuropathy--pathogenesis and precipitating factors].
    Wasada T
    Nihon Rinsho; 1991 Feb; 49 Suppl():159-65. PubMed ID: 1851896
    [No Abstract]   [Full Text] [Related]  

  • 60. A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats.
    Yasuda H; Sonobe M; Hatanaka I; Yamashita M; Miyamoto Y; Terada M; Amenomori M; Kikkawa R; Shigeta Y; Motoyama Y
    Biochem Biophys Res Commun; 1988 Jan; 150(1):225-30. PubMed ID: 3276309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.